ALUPENT Drug Patent Profile
✉ Email this page to a colleague
When do Alupent patents expire, and when can generic versions of Alupent launch?
Alupent is a drug marketed by Boehringer Ingelheim and is included in five NDAs.
The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alupent
A generic version of ALUPENT was approved as metaproterenol sulfate by GENUS on July 22nd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALUPENT?
- What are the global sales for ALUPENT?
- What is Average Wholesale Price for ALUPENT?
Summary for ALUPENT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Patent Applications: | 4,626 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALUPENT at DailyMed |
![ALUPENT drug patent expirations Drug patent expirations by year for ALUPENT](/p/graph/s/t/ALUPENT-patent-expirations.png)
US Patents and Regulatory Information for ALUPENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | ALUPENT | metaproterenol sulfate | AEROSOL, METERED;INHALATION | 016402-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | ALUPENT | metaproterenol sulfate | TABLET;ORAL | 015874-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | ALUPENT | metaproterenol sulfate | SOLUTION;INHALATION | 017659-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | ALUPENT | metaproterenol sulfate | SOLUTION;INHALATION | 018761-002 | Oct 10, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | ALUPENT | metaproterenol sulfate | SOLUTION;INHALATION | 018761-001 | Jun 30, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | ALUPENT | metaproterenol sulfate | TABLET;ORAL | 015874-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALUPENT
International Patents for ALUPENT
See the table below for patents covering ALUPENT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Switzerland | 410008 | Verfahren zur Herstellung neuer Aminoalkohole | ⤷ Sign Up |
African Intellectual Property Organization (OAPI) | 1090 | ⤷ Sign Up | |
France | 922 | ⤷ Sign Up | |
Germany | 1275069 | 1-(3', 5'-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoalkane und Verfahren zu ihrer Herstellung | ⤷ Sign Up |
France | 1466215 | Procédé pour la préparation de nouveaux amino-alcools | ⤷ Sign Up |
Belgium | 611502 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |